Company / Current Liabilities
Moderna Current Liabilities History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$2.0B
FY2025
5-year range
$2.0B / $9.1B
FY2021-FY2025
Trend
-9.9%
vs FY2024
Sector context
#18 of 213
Health Care
What the data says
Among 213 Health Care companies, Moderna is in the bottom 8% for current liabilities. Current Liabilities has declined for 4 consecutive years, from $9.1B in FY2021 to $2.0B in FY2025.
Based on SEC 10-K filings.
$2.0B in FY2025 with a 5-year CAGR of -14.7%. Top quartile in the Health Care sector.
Improved from $3.0B to $2.0B over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -26.1%
- 5-Year CAGR
- -14.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 213This company $2.0B Sector average $1.6B
▼
+25.1% above sector average
Key checks
Key Insights
- Moderna's current liabilities has declined for 4 consecutive years.
- 5-year CAGR of -14.7%, indicating a declining trend.
- In FY2025, current liabilities decreased 9.9% year-over-year.
- Ranks #18 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.0B | -9.9% |
| FY2024 | $2.2B | -26.8% |
| FY2023 | $3.0B | -38.8% |
| FY2022 | $4.9B | -46.1% |
| FY2021 | $9.1B | +108.0% |
| FY2020 | $4.4B | +2966.8% |
| FY2019 | $143.1M | -35.8% |
| FY2018 | $222.8M | +16.4% |
| FY2017 | $191.5M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026